BRPI0807404A2 - Uso de um composto - Google Patents

Uso de um composto

Info

Publication number
BRPI0807404A2
BRPI0807404A2 BRPI0807404-6A2A BRPI0807404A BRPI0807404A2 BR PI0807404 A2 BRPI0807404 A2 BR PI0807404A2 BR PI0807404 A BRPI0807404 A BR PI0807404A BR PI0807404 A2 BRPI0807404 A2 BR PI0807404A2
Authority
BR
Brazil
Prior art keywords
groups
compound
alkylidyne
cycloalkylene
cycloalkyl
Prior art date
Application number
BRPI0807404-6A2A
Other languages
English (en)
Inventor
Jacques Ferte
Hugues Bienayme
Francisco Carlos Perez Martinez
Original Assignee
Urogene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogene filed Critical Urogene
Publication of BRPI0807404A2 publication Critical patent/BRPI0807404A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0807404-6A2A 2007-01-26 2008-01-28 Uso de um composto BRPI0807404A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0700548A FR2911780A1 (fr) 2007-01-26 2007-01-26 Traitement de l'incontinence fecale.
US89871307P 2007-02-01 2007-02-01
PCT/IB2008/001296 WO2008090480A2 (en) 2007-01-26 2008-01-28 Treatment of faecal incontinence

Publications (1)

Publication Number Publication Date
BRPI0807404A2 true BRPI0807404A2 (pt) 2014-05-20

Family

ID=38171270

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807404-6A2A BRPI0807404A2 (pt) 2007-01-26 2008-01-28 Uso de um composto

Country Status (17)

Country Link
US (1) US20100063102A1 (pt)
EP (1) EP2114530B1 (pt)
JP (1) JP2010516753A (pt)
KR (1) KR20090107551A (pt)
CN (1) CN101610812A (pt)
AT (1) ATE474576T1 (pt)
AU (1) AU2008208627A1 (pt)
BR (1) BRPI0807404A2 (pt)
CA (1) CA2674636A1 (pt)
DE (1) DE602008001877D1 (pt)
FR (1) FR2911780A1 (pt)
IL (1) IL199723A0 (pt)
MA (1) MA31157B1 (pt)
MX (1) MX2009007850A (pt)
RU (1) RU2009124635A (pt)
WO (1) WO2008090480A2 (pt)
ZA (1) ZA200905208B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6289362B2 (ja) * 2011-04-26 2018-03-07 アールディーディー ファーマ リミテッド 肛門直腸疾患の処置のためのオキシメタゾリン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
FR2892021B1 (fr) * 2005-10-19 2008-01-04 Urogene Traitement de l'incontinence urinaire d'effort et mixte

Also Published As

Publication number Publication date
MX2009007850A (es) 2009-08-24
JP2010516753A (ja) 2010-05-20
RU2009124635A (ru) 2011-03-10
MA31157B1 (fr) 2010-02-01
EP2114530B1 (en) 2010-07-21
WO2008090480A3 (en) 2008-11-06
IL199723A0 (en) 2010-04-15
CA2674636A1 (en) 2008-07-31
CN101610812A (zh) 2009-12-23
FR2911780A1 (fr) 2008-08-01
ATE474576T1 (de) 2010-08-15
EP2114530A2 (en) 2009-11-11
US20100063102A1 (en) 2010-03-11
DE602008001877D1 (de) 2010-09-02
KR20090107551A (ko) 2009-10-13
WO2008090480A2 (en) 2008-07-31
AU2008208627A1 (en) 2008-07-31
ZA200905208B (en) 2010-04-28

Similar Documents

Publication Publication Date Title
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
EA200701504A1 (ru) Индолы, пригодные для лечения воспалений
EA200900924A1 (ru) Циклизованные производные как ингибиторы eg-5
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
CR20120190A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
ES2531009T3 (es) Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
NZ612000A (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
BR112013028666A2 (pt) compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
DK1697371T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
GT201200158A (es) Procedimiento para la preparación de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}metilcarbamato de metilo y su purificación para su uso como principio activo farmacéutico
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201270540A1 (ru) Макроциклические ингибиторы интегразы
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
RS54438B1 (en) PHARMACEUTICAL DOSAGE FORM CONTAINING 6`-FLUORO- (N-METHYL-OR N, N-DIMETHYL) - 4-PHENYL-4`, 9`-DIHYDRO-3`H-SPIRO [CYCLOHEXANE-1,1`-PIRANO [3,4, B] INDOL] -4-AMINE
TW200833324A (en) Sulfonamide derivatives
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
GEP20156368B (en) Non-nucleoside reverse transcriptase inhibitors
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3
EA201170722A1 (ru) Лактамы в качестве ингибиторов бета-секретазы
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 4A, 5A E 6A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.